Nypt Rehab Services | |
6607 Alderton St, Rego Park, NY 11374-5234 | |
(718) 275-7790 | |
(718) 358-3837 |
Full Name | Nypt Rehab Services |
---|---|
Type | Facility |
Speciality | Physical Therapist |
Location | 6607 Alderton St, Rego Park, New York |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043331150 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 013300-1 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Nypt Rehab Services 20814 Richland Ave, Oakland Gardens, NY 11364-3231 Ph: (718) 776-6209 | Nypt Rehab Services 6607 Alderton St, Rego Park, NY 11374-5234 Ph: (718) 275-7790 |
News Archive
The Associated Press reports that Ugandan President Yoweri Museveni has said that the anti-gay bill to be considered late next month or early March by the country's parliament "is too harsh and [he] has encouraged his ruling National Resistance Movement Party to overturn the death sentence provision. Several lawmakers have agreed and say they will push to remove the statute."
The success of the Affordable Care Act's online marketplaces may depend on people like [26-year-old] Lizzie Bunnen. If healthy adults her age don't sign up, the risk is that predominantly older and sicker members will drive up costs and threaten the portals' future. With the Dec. 23 deadline approaching for January coverage, and at the end of March for all 2014 enrollment, the clock is ticking on what many believe is one of the health law's biggest challenges.
In an announcement today, Humanetics Corporation reported that its BIO 300 medical radiation countermeasure drug candidate has been issued a U.S. patent. The patent is assigned to the United States of America with Humanetics as the designated licensee.
BioTrends Research Group, Inc. announces the release of the final wave of LaunchTrends®: Simponi and Cimzia report. The survey was completed by U.S. Rheumatologists.
The U.S. Food and Drug Administration today granted accelerated approval for Keytruda (pembrolizumab) to treat patients with advanced (metastatic) non-small cell lung cancer (NSCLC) whose disease has progressed after other treatments and with tumors that express a protein called PD-L1. Keytruda is approved for use with a companion diagnostic, the PD-L1 IHC 22C3 pharmDx test, the first test designed to detect PD-L1 expression in non-small cell lung tumors.
› Verified 6 days ago
Mr. Nino Pompeyo Rocco Altamirano Borja, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 6241 Woodhaven Blvd, Rego Park, NY 11374 Phone: 929-607-3271 Fax: 929-607-3267 | |
Lichieh Pao, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 6541 Wetherole St, Rego Park, NY 11374 Phone: 917-862-7787 | |
Mikaela Adriano Lagman, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 98120 Queens Blvd Ste 1lm, Rego Park, NY 11374 Phone: 718-897-3333 Fax: 718-997-0342 | |
Ralph Arden Paul Fuster Murillo, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6288 Austin St, Rego Park, NY 11374 Phone: 718-314-5849 | |
Rhyan Fermin Florendo, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 9748 64th Ave Fl 2, Rego Park, NY 11374 Phone: 510-367-7730 | |
Stephanie Patricia Siry, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6601 Burns St Apt 6y, Rego Park, NY 11374 Phone: 646-418-9513 |